AbbVie: Conjunctivitis trials

The registry lists 11 Conjunctivitis studies with AbbVie as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 2 1Phase 3 5Phase 4 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic ConjunctivitisCompletedNCT02161146Phase 3Results posted
• AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic ConjunctivitisCompletedNCT02082262Phase 3Results posted
• Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in KoreaCompletedNCT01987765Results posted
• AGN-229666 for the Treatment of Allergic ConjunctivitisCompletedNCT01754766Phase 2Results posted
• A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic ConjunctivitisCompletedNCT01732757Phase 4Results posted
• A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic ConjunctivitisCompletedNCT01470118Phase 4Results posted
• A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial ConjunctivitisCompletedNCT00518089Phase 3Results posted
• A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial ConjunctivitisCompletedNCT00509873Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial ConjunctivitisCompletedNCT00464438Phase 4Results posted
• Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in KoreaCompletedNCT02555761
• Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic ConjunctivitisCompletedNCT01258309Phase 3